【字节拆出一家AI制药公司,首轮融资2.9亿美元,估值15亿美元】9月16日,据市场消息,自字节跳动分拆出来的AI制药业务Anew Labs独立完成2.9亿美元首轮融资,投后估值约15亿美元。字节跳动保留56%股份,保持控股地位。本轮融资由HSG、IDG资本和高瓴投资领投,五源资本联合领投,战略投资者包括中国生物制药及上海未来产业基金。截至发稿,字节跳动方面暂未回应。Anew Labs前身为字节跳动内部AI for Science药物发现团队,2021年由刘凯牵头组建,核心成员约50人。早在2020年底,字节AI Lab就开始招聘AI制药领域人才。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.